APA (7th ed.) Citation

C, d. l. C., AV, d. C., GL, D., AM, L. G., C, G., M, M., . . . R, R. (2017). Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America. The Journal of dermatology, 44(1), 3. https://doi.org/10.1111/1346-8138.13512

Chicago Style (17th ed.) Citation

C, de la Cruz, et al. "Biosimilars in Psoriasis: Clinical Practice and Regulatory Perspectives in Latin America." The Journal of Dermatology 44, no. 1 (2017): 3. https://doi.org/10.1111/1346-8138.13512.

MLA (9th ed.) Citation

C, de la Cruz, et al. "Biosimilars in Psoriasis: Clinical Practice and Regulatory Perspectives in Latin America." The Journal of Dermatology, vol. 44, no. 1, 2017, p. 3, https://doi.org/10.1111/1346-8138.13512.